Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Phone tools help young thai men stick with HIV prevention

NCT ID NCT05243030

Prevention Sponsor: University of Massachusetts, Worcester Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether mobile health tools (like text messages and apps) can help young Thai men who have sex with men start and keep taking HIV pre-exposure prophylaxis (PrEP). 119 HIV-negative men aged 16-25 at risk for HIV took part. Researchers measured how acceptable and feasible the tools were, and whether they improved PrEP use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

119 people

The number who actually took part.

Started

Feb 2022

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

16 to 25 years

Sex

Male participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 16-25 years old * Men who report sex with men in the past 12 months * Confirmed HIV-negative status * Self-reported evidence of being at-risk for HIV acquisition, including one of the following in the past 6 months: 1. having a sex with an HIV-positive partner 2. having anal sex 3. without using a condom 4. being diagnosed with an STI or 5. having any illicit drug use (e.g., Amphetamine type stimulants) * Able to understand, read and speak Thai * Either having not started PrEP (Group 1: PrEP naive) or currently on PrEP but not adherent to PrEP (taking ≤3 pills/week) in the past month (Group 2: PrEP users). Exclusion Criteria: * In a mutually monogamous relationship of more than 6 months with a partner who recently tested HIV-negative * Have a serious cognitive or psychiatric problem that would compromise ability to provide informed consent * currently enrolled in another HIV intervention study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pre-exposure prophylaxis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pre-exposure prophylaxis

Contacts and locations

Locations

  • Institute of HIV Research and Innovation

    Bangkok, Bangkok, 10330, Thailand

  • Rainbow Sky Association of Thailand

    Bangkok, Bangkok, 10240, Thailand

  • SWING Foundation

    Bangkok, Bangkok, 10500, Thailand

More trials for these conditions

Other studies related to the condition(s) this trial covers.